Significantly increased TIMP1 levels were also detected in patients with astrocytomas and glioblastomas compared to patients with meningiomas (p < 0.001 and p = 0.024, respectively), and in patients with glioblastomas compared to those with astrocytomas (p < 0.001). This evidence concerns the gene TIMP1 and glioblastoma.